Vir Biotechnology, Inc. (VIR) Stock Analysis

Vir Biotechnology, Inc. (VIR) Stock Analysis — AI Research | MarketCI

VIR

Market Closed

Vir Biotechnology, Inc.

NASDAQHealthcare Biotechnology

367 employees

CEO: Marianne De Backer

Founded: 2019

$9.59

+$0.00(+NaN%)

Market Cap

1.62B

Beta

1.62

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

VIR Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for VIR built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

14.29%

Score

1/7

Fair Value Estimate

Cash flow analysis • Multiple methods

-$72.32

AI Price Target

Machine learning • Price prediction

$8.92

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

1.36

Quality Score

Financial strength rating

3.00

AI Investment Grade

Deep analysis of filings & news

52.00

Key Investment Highlights

Important factors affecting VIR investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

31.58% Poor

Conditions Met

12.00/38.00

Due Diligence Score

31.58%

Due Diligence Conditions

Investment analysis conditions and results


	Fail
	Fail
	Fail
	Fail
	Fail
	Fail

Showing 1 to 6 of 46 conditions